Immunome, Inc. Common Stock (NASDAQ: IMNM) last traded at $17.20, down 2.16% on the session. The quote above updates while this page is open; the figures below are drawn from Immunome, Inc. Common Stock’s own filings and are restated only when a new one is published.
Immunome, Inc. Common Stock trades on NASDAQ under the ticker IMNM. Its market capitalisation is $1.95 billion.
Valuation measures for Immunome, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.95B |
|---|---|
| Enterprise value | $1.78B |
| Price / book | 3.72 |
| Beta | 1.60 |
Trailing-twelve-month figures tagged in Immunome, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$254.32M |
|---|
| EPS (TTM) | -$2.54 |
|---|
| Return on equity | -48.43% |
|---|
| Cash | $217.71M |
|---|
Range and volume for IMNM over the past 52 weeks.
| 52-week high | $30.06 |
|---|---|
| 52-week low | $13.94 |
| Volume | 1.15M |
| Average volume | 1.20M |
| Previous close | $17.58 |
Invest a chosen dollar amount in Immunome, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell IMNM.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.